Lorenz M. Mayr
Life Sciences and BioPharma Professional.
Previously, he was the Chief Technology Officer for GE Healthcare Life Sciences, overseeing R&D investment, research programmes and business growth strategy. Prior to this he held senior leadership positions at Novartis, Astra Zeneca and Bayer. He also holds a position as a Visiting Scientist/Guest Professor at the ETHZ, the Swiss Federal Institute of Technology at Zurich/Switzerland.
Visit website: https://www.synconaltd.com/about-us/our-people/
See also: AstraZeneca - Pharmaceutical and biopharmaceutical company that develops innovative drugs
Details last updated 23-Jul-2020
Lorenz M. Mayr News
Injection could permanently lower cholesterol by changing DNA
New Scientist - 06-Feb-2017
People born with natural mutations that disable a specific gene have a lower risk of heart diseas...
Read more...